Literature DB >> 18214754

Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compound.

Stefanie Siepe1, Barbara Lueckel, Andrea Kramer, Angelika Ries, Robert Gurny.   

Abstract

Tailor-made, pH-controlled matrix minitablets based on different HPMC types were developed comprising the weakly basic drug dipyridamole. The incorporation of pH modifiers, i.e., fumaric and succinic acid, enhanced the drug release at pH 6.8. Assessing the drug release, acid release, and the microenvironmental pH (pHM) provided detailed understanding of pH-controlled mini-matrices. The extent and duration of pHM alteration was more pronounced in presence of fumaric acid. Minitablets based on the fast dissolving Methocel K100LV (< or = 100 cps) showed simultaneous release rates of dipyridamole and fumaric acid with a constant low average pHM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18214754     DOI: 10.1080/03639040701484106

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  5 in total

1.  Silicone adhesive matrix of verapamil hydrochloride to provide pH-independent sustained release.

Authors:  Gaurav Tolia; S Kevin Li
Journal:  AAPS PharmSciTech       Date:  2014-02       Impact factor: 3.246

2.  Design and mechanism of on-off pulsed drug release using nonenteric polymeric systems via pH modulation.

Authors:  Phuong Ha-Lien Tran; Jae-Seung Choe; Thao Truong-Dinh Tran; Young Min Park; Beom-Jin Lee
Journal:  AAPS PharmSciTech       Date:  2010-12-15       Impact factor: 3.246

3.  pH-Dependent supersaturation from amorphous solid dispersions of weakly basic drugs.

Authors:  Bo Wang; Matthew J Nethercott; Akshay Narula; Michael Hanrahan; Shanming Kuang; Robert M Wenslow; Na Li
Journal:  Pharm Res       Date:  2021-12-10       Impact factor: 4.200

4.  Alleviating the Influence of Circadian Rhythms and Drug Properties to the Release of Paliperidone Gel Matrix Tablets with Compression Coating Technology and Microenvironment Shaping.

Authors:  Zherui Zhang; Shumin Chen; Man Wen; Haibing He; Yu Zhang; Tian Yin; Jingxin Gou; Xing Tang
Journal:  AAPS PharmSciTech       Date:  2022-08-16       Impact factor: 4.026

5.  Implementing the Design of Experiments (DoE) Concept into the Development Phase of Orodispersible Minitablets (ODMTs) Containing Melatonin.

Authors:  Arkadiusz Hejduk; Michał Teżyk; Emilia Jakubowska; Klaudia Krüger; Janina Lulek
Journal:  AAPS PharmSciTech       Date:  2022-01-20       Impact factor: 3.246

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.